Proceedings: Inhibition of acetylcholine deactivating enzymes of the horse plasma by heavy metals and arsenic.
D000085:Acetates / Q000494:pharmacology; D000109:Acetylcholine / Q000378:metabolism*; D000409:Alanine / Q000494:pharmacology; D000818:Animals; D001151:Arsenic / Q000494:pharmacology*; D002104:Cadmium / Q000494:pharmacology; D003300:Copper / Q000494:pharmacology; D003545:Cysteine / Q000494:pharmacology; D004112:Dimercaprol / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004798:Enzymes / Q000097:blood*; D006736:Horses; D066298:In Vitro Techniques; D007501:Iron / Q000494:pharmacology; D007854:Lead / Q000494:pharmacology; D008628:Mercury / Q000494:pharmacology; D008670:Metals / Q000494:pharmacology*; D009566:Nitrates / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D014025:Titanium / Q000494:pharmacology; D015032:Zinc / Q000494:pharmacology
D000085:Acetates; D004798:Enzymes; D008670:Metals; D009566:Nitrates; D002104:Cadmium; D004112:Dimercaprol; D007854:Lead; D003300:Copper; D010830:Physostigmine; D014025:Titanium; D007501:Iron; D008628:Mercury; D015032:Zinc; D003545:Cysteine; D001151:Arsenic; D000109:Acetylcholine; D000409:Alanine